• Something wrong with this record ?

Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation

R. Bruha, Z. Marecek, L. Pospisilova, S. Nevsimalova, L. Vitek, P. Martasek, J. Nevoral, J. Petrtyl, P. Urbanek, A. Jiraskova, P. Ferenci

. 2011 ; 31 (1) : 83-91.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12026708

Grant support
NR9406 MZ0 CEP Register

BACKGROUND AND AIMS: Wilson disease (WD) is an inherited disorder of copper metabolism. When treated, the outcome can be excellent, although the long-term survival has yet to be well documented. The aim of this study was to describe the long-term outcome of a cohort of patients with WD and to assess those factors affecting the phenotypic manifestation of WD. METHODS: The presence of mutations to the ATP7B gene, the clinical manifestations, treatments and the long-term outcomes were analysed retrospectively in 117 patients with WD (59 men and 58 women, aged at evaluation 38.5 ± 11, range 16-63 years). RESULTS: Fifty-five patients with a neurological presentation, 51 patients with a hepatic presentation and 11 asymptomatic patients were followed up for an average of 15.1 ± 10 years (median 12 years, range 1-41 years). The H1069Q ATP7B gene mutation was the most frequent genetic variant (54.3%); the frequency of this mutation did not differ between patients with either the hepatic or the neurological presentation (P = 0.099). d-penicillamine or zinc salts (81 and 17% respectively) were used for treatment, and three patients underwent liver transplantation. The majority of symptomatic patients became asymptomatic, or improved, during the follow-up (82% patients with hepatic presentation, 69% with neurological presentation). The long-term survival of patients with WD did not differ from that of the general Czech population (P = 0.95). CONCLUSIONS: Long-term follow-up shows a satisfactory response in the great majority of adequately treated patients with WD and survival coincides with that of the general population.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026708
003      
CZ-PrNML
005      
20160322104909.0
007      
ta
008      
120816s2011 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1111/j.1478-3231.2010.02354.x $2 doi
035    __
$a (PubMed)20958917
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Brůha, Radan, $d 1964- $7 xx0031692 $u 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, General Teaching Hospital, Prague, Czech Republic. bruha@cesnet.cz
245    10
$a Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation / $c R. Bruha, Z. Marecek, L. Pospisilova, S. Nevsimalova, L. Vitek, P. Martasek, J. Nevoral, J. Petrtyl, P. Urbanek, A. Jiraskova, P. Ferenci
520    9_
$a BACKGROUND AND AIMS: Wilson disease (WD) is an inherited disorder of copper metabolism. When treated, the outcome can be excellent, although the long-term survival has yet to be well documented. The aim of this study was to describe the long-term outcome of a cohort of patients with WD and to assess those factors affecting the phenotypic manifestation of WD. METHODS: The presence of mutations to the ATP7B gene, the clinical manifestations, treatments and the long-term outcomes were analysed retrospectively in 117 patients with WD (59 men and 58 women, aged at evaluation 38.5 ± 11, range 16-63 years). RESULTS: Fifty-five patients with a neurological presentation, 51 patients with a hepatic presentation and 11 asymptomatic patients were followed up for an average of 15.1 ± 10 years (median 12 years, range 1-41 years). The H1069Q ATP7B gene mutation was the most frequent genetic variant (54.3%); the frequency of this mutation did not differ between patients with either the hepatic or the neurological presentation (P = 0.099). d-penicillamine or zinc salts (81 and 17% respectively) were used for treatment, and three patients underwent liver transplantation. The majority of symptomatic patients became asymptomatic, or improved, during the follow-up (82% patients with hepatic presentation, 69% with neurological presentation). The long-term survival of patients with WD did not differ from that of the general Czech population (P = 0.95). CONCLUSIONS: Long-term follow-up shows a satisfactory response in the great majority of adequately treated patients with WD and survival coincides with that of the general population.
650    _2
$a adenosintrifosfatasy $x genetika $x metabolismus $7 D000251
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a asymptomatické nemoci $7 D058070
650    _2
$a proteiny přenášející kationty $x genetika $x metabolismus $7 D027682
650    _2
$a chelátory $x metabolismus $7 D002614
650    _2
$a rozdělení chí kvadrát $7 D016009
650    _2
$a měď $x metabolismus $7 D003300
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a hepatolentikulární degenerace $x enzymologie $x genetika $x mortalita $x terapie $7 D006527
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a transplantace jater $7 D016031
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a penicilamin $x terapeutické užití $7 D010396
650    _2
$a fenotyp $7 D010641
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
650    _2
$a octan zinečnatý $x terapeutické užití $7 D019345
650    _2
$a síran zinečnatý $x terapeutické užití $7 D019287
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mareček, Zdeněk, $d 1938- $7 nlk19990073533 $u Department of Internal Medicine, 1st Faculty of Medicine and Central Military Hospital, Charles University in Prague, Prague, Czech Republic
700    1_
$a Pospíšilová, Lenka $7 _BN007775 $u Laboratory for Mitochondrial Disorders, Department of Pediatrics, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Nevšímalová, Soňa, $d 1940- $7 nlk19990073606 $u Department of Neurology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Vítek, Libor, $d 1969- $7 xx0035071 $u 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, General Teaching Hospital, Prague, Czech Republic
700    1_
$a Martásek, Pavel, $d 1952- $7 xx0077949 $u Laboratory for Mitochondrial Disorders, Department of Pediatrics, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Nevoral, Jiří, $d 1942- $7 jn19990202013 $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Petrtýl, Jaromír, $d 1958- $7 xx0089233 $u 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, General Teaching Hospital, Prague, Czech Republic
700    1_
$a Urbánek, Petr, $d 1969- $7 jn20001103565 $u Department of Internal Medicine, 1st Faculty of Medicine and Central Military Hospital, Charles University in Prague, Prague, Czech Republic
700    1_
$a Jirásková, Alena $7 _BN007805 $u 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague, General Teaching Hospital, Prague, Czech Republic
700    1_
$a Ferenci, P. $7 _BN007779 $u Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
773    0_
$w MED00007623 $t Liver international official journal of the International Association for the Study of the Liver $x 1478-3231 $g Roč. 31, č. 1 (2011), s. 83-91
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20958917 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160322104937 $b ABA008
999    __
$a ok $b bmc $g 948750 $s 784054
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 31 $c 1 $d 83-91 $i 1478-3231 $m Liver international $n Liver Int $x MED00007623
GRA    __
$a NR9406 $p MZ0
LZP    __
$b NLK122 $a Pubmed-20120816/11/01

Find record

Citation metrics

Archiving options